These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27650600)

  • 1. Cytology training in the UK: a training centre prospective.
    Dudding N
    Cytopathology; 2016 Oct; 27(5):321-4. PubMed ID: 27650600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of a quality assurance programme for HPV testing within the UK NHS cervical screening LBC/HPV studies.
    Cubie HA; Moore C; Waller M; Moss S;
    J Clin Virol; 2005 Aug; 33(4):287-92. PubMed ID: 16036178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Wright TC
    Clin Obstet Gynecol; 2007 Jun; 50(2):313-23. PubMed ID: 17513921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary human papillomavirus testing in organized cervical screening.
    Dillner J
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):11-6. PubMed ID: 23299089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting.
    Kotaniemi-Talonen L; Nieminen P; Anttila A; Hakama M
    Br J Cancer; 2005 Oct; 93(8):862-7. PubMed ID: 16189520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary HPV testing: a proposal for co-testing in initial rounds of screening to optimise sensitivity of cervical cancer screening.
    Herbert A
    Cytopathology; 2017 Feb; 28(1):9-15. PubMed ID: 27005867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
    Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
    Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.
    Wright TC; Schiffman M; Solomon D; Cox JT; Garcia F; Goldie S; Hatch K; Noller KL; Roach N; Runowicz C; Saslow D
    Obstet Gynecol; 2004 Feb; 103(2):304-9. PubMed ID: 14754700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer.
    Kim JH; Kim IW; Kim YW; Park DC; Kim YW; Lee KH; Ahn TG; Han SJ; Ahn WS
    Oncol Rep; 2013 Apr; 29(4):1645-51. PubMed ID: 23443346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating human papillomavirus testing into cytological screening in the era of prophylactic vaccines.
    Almonte M; Sasieni P; Cuzick J
    Best Pract Res Clin Obstet Gynaecol; 2011 Oct; 25(5):617-29. PubMed ID: 21683657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
    Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
    Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid based cytology: a new cervical screening system for the UK.
    Wall A
    J Fam Health Care; 2005; 15(3):90-2. PubMed ID: 16094904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening of cervical cancer--update].
    Dvorák V; Ondrus J
    Ceska Gynekol; 2010 Feb; 75(1):65-8. PubMed ID: 20437841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why lesbians should be encouraged to have regular cervical screening.
    Henderson HJ
    J Fam Plann Reprod Health Care; 2009 Jan; 35(1):49-52. PubMed ID: 19126320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The health and economic effects of HPV DNA screening in The Netherlands.
    Berkhof J; Coupé VM; Bogaards JA; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ
    Int J Cancer; 2010 Nov; 127(9):2147-58. PubMed ID: 20112339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytology at the Time of HPV: Some Things to Think about when Discussing HPV.
    Valentine K; Vanden Broeck D; Benoy I; Truyens M; Bogers J
    Acta Cytol; 2016; 60(6):527-533. PubMed ID: 27816982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a technical external quality assurance scheme in non-gynaecological cytology in UK.
    Cross PA; Hodgson C; Crossley J; Crossley B
    Cytopathology; 2015 Apr; 26(2):71-4. PubMed ID: 25800804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer screening in the early post vaccine era.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.